1. Home
  2. EB vs MYGN Comparison

EB vs MYGN Comparison

Compare EB & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eventbrite Inc.

EB

Eventbrite Inc.

N/A

Current Price

$4.51

Market Cap

442.9M

Sector

Technology

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$4.81

Market Cap

481.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EB
MYGN
Founded
2003
1991
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
442.9M
481.6M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
EB
MYGN
Price
$4.51
$4.81
Analyst Decision
Buy
Hold
Analyst Count
2
9
Target Price
$5.00
$8.06
AVG Volume (30 Days)
998.4K
1.3M
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
34.62
N/A
EPS
N/A
N/A
Revenue
$326,134,000.00
$771,400,000.00
Revenue This Year
N/A
$7.19
Revenue Next Year
$4.70
$5.64
P/E Ratio
N/A
N/A
Revenue Growth
24.99
2.33
52 Week Low
$1.81
$3.76
52 Week High
$4.48
$11.44

Technical Indicators

Market Signals
Indicator
EB
MYGN
Relative Strength Index (RSI) 76.38 43.74
Support Level $4.43 $3.93
Resistance Level N/A $5.67
Average True Range (ATR) 0.02 0.39
MACD 0.00 0.11
Stochastic Oscillator 95.45 44.41

Price Performance

Historical Comparison
EB
MYGN

About EB Eventbrite Inc.

Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: